These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 22160397)

  • 1. Can vitamin D slow down the progression of chronic kidney disease?
    Shroff R; Wan M; Rees L
    Pediatr Nephrol; 2012 Dec; 27(12):2167-73. PubMed ID: 22160397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cross talk between the renin-angiotensin-aldosterone system and vitamin D-FGF-23-klotho in chronic kidney disease.
    de Borst MH; Vervloet MG; ter Wee PM; Navis G
    J Am Soc Nephrol; 2011 Sep; 22(9):1603-9. PubMed ID: 21852584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitamin D in chronic kidney disease: new potential for intervention.
    Mirković K; van den Born J; Navis G; de Borst MH
    Curr Drug Targets; 2011 Jan; 12(1):42-53. PubMed ID: 20795938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of Vitamin D with Peptide Hormones with Emphasis on Parathyroid Hormone, FGF23, and the Renin-Angiotensin-Aldosterone System.
    Latic N; Erben RG
    Nutrients; 2022 Dec; 14(23):. PubMed ID: 36501215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Normal 25-Hydroxyvitamin D Levels Are Associated with Less Proteinuria and Attenuate Renal Failure Progression in Children with CKD.
    Shroff R; Aitkenhead H; Costa N; Trivelli A; Litwin M; Picca S; Anarat A; Sallay P; Ozaltin F; Zurowska A; Jankauskiene A; Montini G; Charbit M; Schaefer F; Wühl E;
    J Am Soc Nephrol; 2016 Jan; 27(1):314-22. PubMed ID: 26069294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphate and FGF23 in the renoprotective benefit of RAAS inhibition.
    de Seigneux S; Martin PY
    Pharmacol Res; 2016 Apr; 106():87-91. PubMed ID: 26900884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitamin D analogues to target residual proteinuria: potential impact on cardiorenal outcomes.
    Humalda JK; Goldsmith DJ; Thadhani R; de Borst MH
    Nephrol Dial Transplant; 2015 Dec; 30(12):1988-94. PubMed ID: 25609737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Possible renoprotection by vitamin D in chronic renal disease: beyond mineral metabolism.
    Doorenbos CR; van den Born J; Navis G; de Borst MH
    Nat Rev Nephrol; 2009 Dec; 5(12):691-700. PubMed ID: 19859070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of new vitamin D data on future studies and treatment.
    Bhan I; Tamez H; Thadhani R
    Curr Opin Nephrol Hypertens; 2013 Jul; 22(4):377-82. PubMed ID: 23666416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitamin D and cardiovascular disease in chronic kidney disease.
    Kaur G; Singh J; Kumar J
    Pediatr Nephrol; 2019 Dec; 34(12):2509-2522. PubMed ID: 30374603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New insights on the role of vitamin D in the progression of renal damage.
    Lucisano S; Buemi M; Passantino A; Aloisi C; Cernaro V; Santoro D
    Kidney Blood Press Res; 2013; 37(6):667-78. PubMed ID: 24356557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Active vitamin D is cardioprotective in experimental uraemia but not in children with CKD Stages 3-5.
    Schön A; Leifheit-Nestler M; Deppe J; Fischer DC; Bayazit AK; Obrycki L; Canpolat N; Bulut IK; Azukaitis K; Yilmaz A; Mir S; Yalcinkaya F; Soylemezoglu O; Melk A; Stangl GI; Behnisch R; Shroff R; Bacchetta J; Querfeld U; Schaefer F; Haffner D;
    Nephrol Dial Transplant; 2021 Feb; 36(3):442-451. PubMed ID: 33241290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pathologies of calcium-phosphate homeostasis].
    Karczmarewicz E; Czekuć-Kryskiewicz E; Lorenc RS
    Postepy Biochem; 2012; 58(4):474-7. PubMed ID: 23662440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Addition of vitamin D reverses the decline in GFR following treatment with ACE inhibitors/angiotensin receptor blockers in patients with chronic kidney disease.
    Soares AE; Maes M; Godeny P; Matsumoto AK; Barbosa DS; da Silva TAF; Souza FHMO; Delfino VDA
    Life Sci; 2017 Dec; 191():175-179. PubMed ID: 29079468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of vitamin D in chronic kidney disease patients.
    Gal-Moscovici A; Sprague SM
    Kidney Int; 2010 Jul; 78(2):146-51. PubMed ID: 20505658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Vitamin D and kidney diseases].
    Cavalier É; Thervet É; Courbebaisse M
    Presse Med; 2013 Oct; 42(10):1391-7. PubMed ID: 24055557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of nutritional vitamin D supplementation on markers of bone and mineral metabolism in children with chronic kidney disease.
    Lerch C; Shroff R; Wan M; Rees L; Aitkenhead H; Kaplan Bulut I; Thurn D; Karabay Bayazit A; Niemirska A; Canpolat N; Duzova A; Azukaitis K; Yilmaz E; Yalcinkaya F; Harambat J; Kiyak A; Alpay H; Habbig S; Zaloszyc A; Soylemezoglu O; Candan C; Rosales A; Melk A; Querfeld U; Leifheit-Nestler M; Sander A; Schaefer F; Haffner D; ;
    Nephrol Dial Transplant; 2018 Dec; 33(12):2208-2217. PubMed ID: 29481636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Role for Protein Restriction in Addition to Renin-Angiotensin-Aldosterone System Inhibitors in the Management of CKD.
    Koppe L; Fouque D
    Am J Kidney Dis; 2019 Feb; 73(2):248-257. PubMed ID: 30149957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving the efficacy of RAAS blockade in patients with chronic kidney disease.
    Lambers Heerspink HJ; de Borst MH; Bakker SJ; Navis GJ
    Nat Rev Nephrol; 2013 Feb; 9(2):112-21. PubMed ID: 23247573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Guidelines for vitamin D prescription in dialysis patients].
    Jean G; Lafage-Proust MH; Massy ZA; Drüeke TB
    Nephrol Ther; 2009 Nov; 5(6):520-32. PubMed ID: 19748843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.